+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
From
From
From
From
From
From
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024 - Product Thumbnail Image

Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024

  • Report
  • September 2024
  • 250 Days
  • Global
From
Cancer Supportive Care Market 2024-2028 - Product Thumbnail Image

Cancer Supportive Care Market 2024-2028

  • Report
  • October 2024
  • 188 Pages
  • Global
From
From
Biosimilar Growth Hormones Global Market Report 2024 - Product Thumbnail Image

Biosimilar Growth Hormones Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
Insulin biosimilars Global Market Report 2024 - Product Thumbnail Image

Insulin biosimilars Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Renal Anemia Therapeutics Market 2024-2028 - Product Thumbnail Image

Renal Anemia Therapeutics Market 2024-2028

  • Report
  • January 2024
  • 160 Pages
  • Global
From
Filgrastim Biosimilars Market Report 2024 - Product Thumbnail Image

Filgrastim Biosimilars Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Loading Indicator